1. Home
  2. TYRA vs FUN Comparison

TYRA vs FUN Comparison

Compare TYRA & FUN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tyra Biosciences Inc.

TYRA

Tyra Biosciences Inc.

HOLD

Current Price

$28.28

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Logo Cedar Fair L.P.

FUN

Cedar Fair L.P.

HOLD

Current Price

$25.05

Market Cap

2.1B

ML Signal

HOLD

Company Overview

Basic Information
Metric
TYRA
FUN
Founded
2018
1983
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Services-Misc. Amusement & Recreation
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
2.1B
IPO Year
2021
2023

Fundamental Metrics

Financial Performance
Metric
TYRA
FUN
Price
$28.28
$25.05
Analyst Decision
Strong Buy
Buy
Analyst Count
11
12
Target Price
$47.50
$23.75
AVG Volume (30 Days)
807.7K
1.8M
Earning Date
05-06-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$3,100,289,000.00
Revenue This Year
N/A
$3.54
Revenue Next Year
N/A
$3.74
P/E Ratio
N/A
N/A
Revenue Growth
N/A
14.45
52 Week Low
$8.98
$12.51
52 Week High
$40.65
$33.50

Technical Indicators

Market Signals
Indicator
TYRA
FUN
Relative Strength Index (RSI) 42.75 68.44
Support Level $27.40 $19.27
Resistance Level $31.57 $26.84
Average True Range (ATR) 1.98 1.25
MACD 0.26 0.30
Stochastic Oscillator 42.12 79.42

Price Performance

Historical Comparison
TYRA
FUN

About TYRA Tyra Biosciences Inc.

Tyra Biosciences Inc is a clinical-stage biotechnology company focused on developing next-generation precision medicines for large opportunities in targeted oncology and genetically defined conditions, harnessing the power of Fibroblast Growth Factor Receptor (FGFR) biology. The company's in-house precision medicine platform, SNAP, enables rapid and precise drug design through iterative molecular SNAPshots that help to design and predict which product candidates may demonstrate the highest potency, selectivity, and tolerability in the clinic. The various drug candidates in the company's product pipeline are FGFR3, FGFR4/3, and FGFR1/2/3: three clinical-stage, novel small molecules designed to overcome the toxicity and resistance liabilities of first-generation pan-FGFR inhibitors.

About FUN Cedar Fair L.P.

Six Flags Entertainment Corp is North America's regional amusement resort operator with approximately 27 amusement parks, around 15 separately gated water parks, and nine resort properties across the U.S., Canada, and Mexico. It provides coasters, themed rides, thrilling water parks, resorts, and a portfolio of beloved intellectual properties such as Looney Tunes, DC Comics, and PEANUTS. The parks are family-oriented, with recreational facilities for people of all ages, and provide clean and attractive environments with exciting rides and immersive entertainment. The Company generates revenue from sales of admission to the amusement parks and water parks, from purchases of food, merchandise and games both inside and outside the parks, from the sale of accommodations and other extra-charge.

Share on Social Networks: